NL-OMON43712已完成4 期
perioperative intravenous insulin, GIK and GLP-1 treatment in diabetes mellitus - PILGRIM
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •* Signed informed consent
- •* known diabetes mellitus type II for > 3 months
- •* aged 18-75 years
- •* scheduled for elective non-cardiac surgery
排除标准
- •* Oral corticosteroid use
- •- Insulin dose > 1IE/kg/day
- •* Planned for day-care (ambulant) surgery
- •* Planned ICU stay post-operatively
- •* History of chronic pancreatitis or idiopathic acute pancreatitis
- •* Impaired renal function defined as serum-creatinine * 133 *mol/L for males and * 115 *mol/L for females
- •* Females of child bearing potential who are pregnant, breast-feeding or intend to become pregnant or are not using adequate contraceptive methods (adequate contraceptive measures as required by local law or practice)
- •* Known or suspected allergy to trial product(s) or related products
- •* Any condition that the local investigator feels would interfere with trial participation or the evaluation of results
- •Planned bowel surgery
研究者
相似试验
进行中（未招募）
1 期
Perioperative intravenous insulin, GIK or GLP-1 treatment in DMEUCTR2012-005291-34-NLAMC, Amsterdam
已完成
不适用
perioperative intensive insulin therapy by continuous glucose monitoring systemhyperglycemiaJPRN-UMIN000028251Tokushima University50
招募中
不适用
Perioperative glycemic control with insulin glargine 300 U/mL versus insulin degludec for surgical patients with type 2 diabetes in non-intensive care unittype 2 diabetesJPRN-UMIN000041001Graduate School of Medicine, Nippon Medical School180
进行中（未招募）
1 期
Do peri-operative high doses of intravenous glucocorticoids improve short-term functional outcome after direct anterior total hip arthroplasty? A randomized, single surgeon, placebo controlled, double blind studyFunctional recovary after total hip arthroplastyEUCTR2019-004834-40-BEniversity Hospitals Leuven70
招募中
不适用
Intravenous immunoglobulin or intralipid treatment for recurrent pregnancy loss or implantation failures women with NK cell abnormalityRecurrent pregnancy loss, implantation failureJPRN-UMIN000038952Hyogo College of Medicine100